Authors:
Hanamura, I
Iida, S
Akano, Y
Hayami, Y
Kato, M
Miura, K
Harada, S
Banno, S
Wakita, A
Kiyoi, H
Naoe, T
Shimizu, S
Sonta, S
Nitta, M
Taniwaki, M
Ueda, R
Citation: I. Hanamura et al., Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations, JPN J CANC, 92(6), 2001, pp. 638-644
Authors:
Hirose, Y
Kiyoi, H
Itoh, K
Kato, K
Saito, H
Naoe, T
Citation: Y. Hirose et al., B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells, IMMUNOLOGY, 104(4), 2001, pp. 410-417
Authors:
Yamamoto, Y
Kiyoi, H
Nakano, Y
Suzuki, R
Kodera, Y
Miyawaki, S
Asou, N
Kuriyama, K
Yagasaki, F
Shimazaki, C
Akiyama, H
Saito, K
Nishimura, M
Motoji, T
Shinagawa, K
Takeshita, A
Saito, H
Ueda, R
Ohno, R
Naoe, T
Citation: Y. Yamamoto et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, BLOOD, 97(8), 2001, pp. 2434-2439
Authors:
Naoe, T
Takeyama, K
Yokozawa, T
Kiyoi, H
Seto, M
Uike, N
Ino, T
Utsunomiya, A
Maruta, A
Jin-Nai, I
Kamada, N
Kubota, Y
Nakamura, H
Shimazaki, C
Horiike, S
Kodera, Y
Saito, H
Ueda, R
Wiemels, J
Ohno, R
Citation: T. Naoe et al., Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia, CLIN CANC R, 6(10), 2000, pp. 4091-4095
Authors:
Hayakawa, F
Towatari, M
Kiyoi, H
Tanimoto, M
Kitamura, T
Saito, H
Naoe, T
Citation: F. Hayakawa et al., Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines, ONCOGENE, 19(5), 2000, pp. 624-631
Authors:
Nakano, Y
Naoe, T
Kiyoi, H
Kitamura, K
Minami, S
Miyawaki, S
Asou, N
Kuriyama, K
Kusumoto, S
Shimazaki, C
Akiyama, H
Saito, K
Nishimura, M
Motoji, T
Shinagawa, K
Saito, H
Ohno, R
Citation: Y. Nakano et al., Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia, EUR J HAEMA, 65(1), 2000, pp. 23-31
Authors:
Zhao, M
Kiyoi, H
Yamamoto, Y
Ito, M
Towatari, M
Omura, S
Kitamura, T
Ueda, R
Saito, H
Naoe, T
Citation: M. Zhao et al., In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor, LEUKEMIA, 14(3), 2000, pp. 374-378
Authors:
Kitamura, K
Minami, Y
Yamamoto, K
Akao, Y
Kiyoi, H
Saito, H
Naoe, T
Citation: K. Kitamura et al., Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis, LEUKEMIA, 14(10), 2000, pp. 1743-1750
Authors:
Yokozawa, T
Towatari, M
Iida, H
Takeyama, K
Tanimoto, M
Kiyoi, H
Motoji, T
Asou, N
Saito, K
Takeuchi, M
Kobayashi, Y
Miyawaki, S
Kodera, Y
Ohno, R
Saito, H
Naoe, T
Citation: T. Yokozawa et al., Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia, LEUKEMIA, 14(1), 2000, pp. 28-33
Authors:
Kitamura, K
Hoshi, S
Koike, M
Kiyoi, H
Saito, H
Naoe, T
Citation: K. Kitamura et al., Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid, BR J HAEM, 108(4), 2000, pp. 696-702
Authors:
Kosugi, H
Towatari, M
Hatano, S
Kitamura, K
Kiyoi, H
Kinoshita, T
Tanimoto, M
Murate, T
Kawashima, K
Saito, H
Naoe, T
Citation: H. Kosugi et al., Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy, LEUKEMIA, 13(9), 1999, pp. 1316-1324
Citation: H. Kiyoi et T. Naoe, Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells, LEUKEMIA, 13(5), 1999, pp. 829-830
Authors:
Iida, M
Towatari, M
Nakao, A
Iida, H
Kiyoi, H
Nakano, Y
Tanimoto, M
Saito, H
Naoe, T
Citation: M. Iida et al., Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation, LEUKEMIA, 13(4), 1999, pp. 585-589
Authors:
Mizuta, S
Ito, Y
Kohno, A
Kiyoi, H
Miyamura, K
Tanimoto, M
Takamatsu, J
Naoe, T
Morishima, Y
Ueda, R
Saito, H
Citation: S. Mizuta et al., Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation, BONE MAR TR, 24(7), 1999, pp. 777-784
Authors:
Nakano, Y
Kiyoi, H
Miyawaki, S
Asou, N
Ohno, R
Saito, H
Naoe, T
Citation: Y. Nakano et al., Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene, BR J HAEM, 104(4), 1999, pp. 659-664
Authors:
Kiyoi, H
Naoe, T
Nakano, Y
Yokota, S
Minami, S
Miyawaki, S
Asou, N
Kuriyama, K
Jinnai, I
Shimazaki, C
Akiyama, H
Saito, K
Oh, H
Motoji, T
Omoto, E
Saito, H
Ohno, R
Ueda, R
Citation: H. Kiyoi et al., Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia, BLOOD, 93(9), 1999, pp. 3074-3080